Filing Flows › Health Catalyst (HCAT) › Accumulated Impairment Losses revenue
Health Catalyst (HCAT) Accumulated Impairment Losses revenue by quarter
Health Catalyst's Accumulated Impairment Losses revenue was $15.6M in Q3 2026 (third quarter 2026), -28% from Q2 2026. Over the last 7 quarters it ranged from $15.6M (Q3 2026) to $27.9M (Q1 2025).
| Quarter | Accumulated Impairment Losses revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $15.6M | -28% | -36% |
| Q2 2026 | $21.7M | +2% | -22% |
| Q1 2026 | $21.3M | -7% | -24% |
| Q4 2025 | $22.8M | -6% | — |
| Q3 2025 | $24.3M | -13% | — |
| Q2 2025 | $27.8M | -0.3% | — |
| Q1 2025 | $27.9M | — | — |
Q3 2026 at a glance
Health Catalyst, Q3 2026: revenue $56.3M (-26% year over year), operating margin 89.1%, net earnings $40.5M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is Health Catalyst's Accumulated Impairment Losses revenue?
Health Catalyst's Accumulated Impairment Losses revenue was $15.6M in Q3 2026 (third quarter 2026), -28% from Q2 2026.
How has Health Catalyst's Accumulated Impairment Losses revenue changed?
Over the last 7 quarters it ranged from $15.6M (Q3 2026) to $27.9M (Q1 2025).